Trial Profile
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2014
Price :
$35
*
At a glance
- Drugs CD4 IgG (Primary)
- Indications Acquired immunodeficiency syndrome
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Genentech
- 24 Oct 2014 New trial record